- Category
- Small (2023-24)
- Udyam number
- UDYAM-UP-29-0020563

Oshino Drugs Private Limited
About Oshino Drugs Private Limited
Data last updated:
Oshino Drugs Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 February 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2000PTC103818. Its GSTIN is 09AAACO4958J1Z0 (Uttar Pradesh).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹19.2 Lakh. It is led by directors Vishal Gupta and Savita Rani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 240 Flat No. 107 1st Floor Pandav Nagar, New Delhi, Delhi, India – 110092.
As per the financials filed for FY 2025, the company reported a revenue of ₹15.75 Cr, a decline of 15% compared to the previous year. For the same year it recorded a net profit of ₹58.96 Lakh (net margin 3.7%) and EBITDA of ₹1.21 Cr (EBITDA margin 7.7%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 14% over five years.
The company has about 2 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹1.22 Cr on record. Court records list 5 cases involving the company, including 5 filed against it.
Oshino Drugs Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-29-0020563). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Oshino Drugs
Contact details
Oshino Drugs Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC – 240 Flat No. 107 1st Floor Pandav Nagar, New Delhi, Delhi, India – 110092
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Oshino Drugs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Oshino Drugs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Oshino Drugs Private Limited, buy the company report.
Financials of Oshino Drugs Private Limited
FY 2025 filings availableOshino Drugs Private Limited reported revenue of ₹15.75 Cr (down 15% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 15% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 14%. EBITDA fell 45% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.21 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹58.96 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.7% | ||||
| Net Profit Margin | 3.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Oshino Drugs Private Limited, buy the company report.
Board of directors of Oshino Drugs Private Limited
Oshino Drugs has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Savita Rani | Additional Director | 07 Jan 2010 | 16 Years 10 Months | Current |
| Vishal Gupta Also directs: Gupta Square Trading LLP, Sylus Pharma India Private Limited | Director | 01 Oct 2005 | 21 Years 1 Months | Current |
Peer comparison
Oshino Drugs Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Oshino Drugs Private Limitedthis company | ₹15.75 Cr (FY 2025) | ₹58.96 Lakh | 3.7% | -15.0% | 2 | New Delhi, Delhi, India |
| Suma Pharmaceuticals Private Limited | ₹15.75 Cr (FY 2024) | 9.0% | Ambernath, Maharashtra, India | |||
| Syntho Pharmaceuticals Private Limited | ₹15.7 Cr (FY 2025) | -3.0% | Uttar Pradesh, India | |||
| Hfa Formulations Private Limited | ₹15.65 Cr (FY 2024) | 42.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Oshino Drugs Private Limited, buy the company report.
Auditor
Oshino Drugs Private Limited is audited by M.C. GARG & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M.C. GARG & CO | FY 2023 | 001251C |
Shareholding
The shareholding of Oshino Drugs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Oshino Drugs Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 May 2024 | 100932764 | Canara Bank | ₹26.32 Lakh | Open | |
| 15 Sep 2018 | 100208785 | Canara Bank | ₹10 Lakh | Open | |
| 31 Jan 2014 | 10496010 | Canara Bank | ₹5.65 Lakh | Open | |
| 24 Sep 2010 | 10244272 | Others | ₹80 Lakh | Open |
To see the full charge records of Oshino Drugs Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
Oshino Drugs Private Limited has 5 court cases on record: 5 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 3 | 0 |
| District courts | 2 | 2 | 0 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, New Delhi, Delhi | Court case (CS (COMM.)) | Filed against the company by M/S Feezo Dhem and Anr | Disposed |
| District court, New Delhi, Delhi | Interim or miscellaneous application | Filed against the company by M/S Feezo Chem and Anr | Disposed |
| Bombay High Court | Court case (COMIP) | Filed against the company by Wockhardt Limited | Disposed |
| Bombay High Court | Court case (NMCD) | Filed against the company by Wockhardt Limited | Disposed |
| Bombay High Court | Court case (LPETN) | Filed against the company by Wockhardt Limited | Disposed |
To see the full case history of Oshino Drugs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Oshino Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Oshino Drugs Private Limited has a workforce of 2 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 2 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 |
To see the full employee and EPFO history of Oshino Drugs Private Limited, buy the company report.
GST
Oshino Drugs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAACO4958J1Z0 | Uttar Pradesh | Active | 27 Jul 2017 |
To see the full GST registrations and return filing status of Oshino Drugs Private Limited, buy the company report.
Recent activity
Oshino Drugs Private Limited has 4 board changes on record since 2005: 2 appointments and 2 cessations. The latest: Payal Gupta ceased to be Director on 07 Jan 2010.
Frequently asked questions
Oshino Drugs is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 February 2000 (26+ years old) and is registered under CIN U24239DL2000PTC103818.
Oshino Drugs has 2 current directors:
- Savita Rani - Additional Director
- Vishal Gupta - Director
The latest financial statements of Oshino Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Oshino Drugs is 09AAACO4958J1Z0, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Oshino Drugs is U24239DL2000PTC103818. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Oshino Drugs has 5 court cases on record: 5 filed against it. Most are in the high courts.
Oshino Drugs was incorporated on 17 February 2000, making it 26+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Oshino Drugs by revenue are Suma Pharmaceuticals Private Limited, Syntho Pharmaceuticals Private Limited, Hfa Formulations Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Payal Gupta ceased to be Director on 07 Jan 2010. Savita Rani was appointed as Additional Director on 07 Jan 2010. Rajesh Kumar Verma ceased to be Director on 06 Aug 2007. Oshino Drugs has 4 board changes on record in total.
Yes, Oshino Drugs is registered as a small enterprise under Udyam registration (number: UDYAM-UP-29-0020563).
The registered office of Oshino Drugs is at C – 240 Flat No. 107 1st Floor Pandav Nagar, New Delhi, Delhi, India – 110092.

